Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

Hindilerden, Fehmi; Yonal-Hindilerden, İPEK; Yenerel, MUSTAFA; Nalcaci, Meliha; Diz-Kucukkaya, Reyhan

doi:10.4274/tjh.2016.0086

Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

Hindilerden F., Yonal-Hindilerden I., Yenerel M. N., Nalcaci M., Diz-Kucukkaya R.

TURKISH JOURNAL OF HEMATOLOGY, cilt.34, sa.1, ss.72-80, 2017 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 34 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.4274/tjh.2016.0086
Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.72-80
Anahtar Kelimeler: Immune thrombocytopenia, Rituximab, Early response, Late response, Sustained response, ANTI-CD20 MONOCLONAL-ANTIBODY, B-CELL DEPLETION, PURPURA, EFFICACY, SAFETY, SPLENECTOMY, MANAGEMENT, CHILDREN
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: This paper prospectively evaluates the long-term follow-up [mean +/- standard deviation (SD) duration: 89.7 +/- 19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rituximab.